Swoop portable MRI update moves toward Europe and U.K. rollout
The approvals cover Hyperfine’s next-generation portable brain MRI system and the latest Optive AI software, with European and U.K. commercialization planned for early Q3 2026.
Hyperfine has received CE Marking and U.K. Conformity Assessment approval for its next-generation Swoop portable brain MRI system and latest Optive AI software. The approvals enable commercialization across the European Economic Area and the U.K.
The next-generation Swoop system received U.S. Food and Drug Administration clearance in Q2 2025. Hyperfine said the updated scanner delivers improvements in image quality, workflow, and user experience compared with the previous generation.
Optive AI, cleared by the FDA in December 2025, includes a multidirection diffusion-weighted imaging sequence. The software acquires and averages images from multiple diffusion directions, using an approach similar to high-field MRI scanners, according to the company.
The DWI capability is intended to produce cleaner and more consistent images for stroke assessment. Hyperfine said the update is designed to improve detection of small strokes and support acute neurological care.
Existing users can access the software as a standalone upgrade. It is also included in the next-generation Swoop system.
Hyperfine’s regulatory-clearance page lists March 2026 CE certification for the Swoop system Model 2 in the European Union and UKCA certification for Model 2 in the U.K. It also lists Optive AI certification for use on Model 1 and Model 2 Swoop systems in both markets.
Commercialization of the next-generation Swoop system and latest Optive AI software in Europe and the U.K. is expected to begin early in Q3 2026 through Hyperfine’s distributor network across more than a dozen countries.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
SimonMed highlights role in large global X-ray AI study
The study analyzed 258,373 X-rays from 100 medical centers across 26 countries and evaluated the Rayvolve AI Suite across trauma, chest, measurement, and bone age use cases.
Former RadNet CTO joins Neurophet as scientific advisor
The neuroradiologist and former RadNet CTO will advise the neuroimaging AI company as it seeks to strengthen clinical validation and U.S. market expansion.
CMR-CLIP AI model interprets cardiac MRI scans with high accuracy
The model was trained on more than 13,000 cardiac MRI studies and linked moving heart images with clinical radiology reports, according to the research team.
Flywheel-AWS link creates governed imaging layer for trials
The integration combines AWS HealthImaging’s cloud-based DICOM storage with Flywheel’s imaging data orchestration tools for clinical trials, research, and AI development.
Free HelloAI training targets practical healthcare AI adoption
The company is making the HelloAI Professional track available at no cost, adding more than 20 hours of on-demand healthcare AI education.
Siemens links coronary CT planning to cath-lab PCI guidance
The system combines Syngo.CT Coronary Cockpit and Syngo PCI Connect to transfer preprocessed coronary CT angiography data into the cath lab.
AZmed gets FDA clearance for expanded AZtrauma scope
The clearance expands AZtrauma beyond fracture detection to include joint effusions and dislocations on X-rays in adults and children ages 2 years and older.
HOPPR breast imaging model converts 2D mammograms into text
The HOPPR EB 2D Mammo Narrative Model generates structured narrative output from 2D mammography images for breast imaging workflow applications.
DeepHealth secures AI clearances for neuro, prostate tools
The regulatory milestones cover Neuro Suite Brain Health and Brain Age, LumbarMR, and Prostate AI within DeepHealth’s clinical AI portfolio.
Philips SmartIQ aims to cut coronary imaging radiation dose
The coronary imaging technology adds an ultra-low-dose protocol for Philips’ Azurion image-guided therapy platform and is available in Europe and selected markets.
Azra AI, RevealDx partner on lung nodule AI
Azra AI will integrate RevealAI-Lung into its incidental findings and oncology workflow platform.
Accuro XV clearance gives Rivanna path into MSK ultrasound
Rivanna received FDA 510(k) clearance for Accuro XV, a diagnostic ultrasound system for musculoskeletal imaging. The company is also developing AI tools for bone visualization and fracture detection.